SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-031184
Filing Date
2019-05-17
Accepted
2019-05-17 20:18:46
Documents
1
Period of Report
2019-05-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4181
  Complete submission text file 0001209191-19-031184.txt   5726
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 129 ELSIE STREET SAN FRANCISCO CA 94110
Business Address
Doberstein Stephen K (Reporting) CIK: 0001480111 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24006 | Film No.: 19837397